Pfizer Inc. buy Guggenheim
Start price
10.02.25
/
50%
€25.02
Target price
10.02.26
€31.98
Performance (%)
-11.37%
Price
26.11.25
€22.18
Summary
This prediction is currently active. The price of Pfizer Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.37%. This prediction currently runs until 10.02.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 2.662% | 2.662% |
| iShares Core DAX® | 2.119% | -1.935% |
| iShares Nasdaq 100 | 1.877% | -0.064% |
| iShares Nikkei 225® | 1.760% | -0.910% |
| iShares S&P 500 | 1.962% | 0.689% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $33.00 price target on the stock.
Ratings data for PFE provided by MarketBeat